The Biomerix Ventral Hernia Repair Mesh, which is the latest addition to Biomerix Corporation's soft tissue repair devices, has received FDA clearance to be marketed.
The Biomerix Ventral Hernia Repair Mesh, which is the latest addition to Biomerix Corportaion’s soft tissue repair devices, has received FDA clearance to be marketed.
The repair mesh features two sides: one side is designed to “promote tissue ingrowth” and the other includes a “resorbable protective film designed to “minimize tissue attachment to the device,” according to a press release from Biomerix Corporation.
The mesh can be used for “hernias and soft tissue deficiencies and for the temporary bridging of fascial defects.”
“The FDA clearance of the Biomerix Ventral Hernia Repair Mesh represents the next generation in ventral and incisional hernia repair prosthesis. We believe the novel Biomerix Biomaterial has desirable scaffold features leading to successful repair outcomes, making it a compelling alternative to other synthetic biomaterials,” said Kenneth G. Hayes, president and chief executive officer of Biomerix Corporation, in a press release.